{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:27:26Z","timestamp":1789504046979,"version":"build-2803163510"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.ejps.2016.09.028","type":"journal-article","created":{"date-parts":[[2016,9,21]],"date-time":"2016-09-21T19:18:14Z","timestamp":1474485494000},"page":"284-289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Nasal drug absorption from powder formulations: The effect of three types of hydroxypropyl cellulose (HPC)"],"prefix":"10.1016","volume":"96","author":[{"given":"Akiko","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Furubayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manami","family":"Tomisaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayuko","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Kusamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidemasa","family":"Katsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyasu","family":"Sakane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2016.09.028_bb0005","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.2500\/ar.2013.4.0065","article-title":"Efficacy of mometasone furoate and fluticasone furoate on persistent allergic rhinoconjunctivitis","volume":"4","author":"Aneeza","year":"2013","journal-title":"Allergy Rhinol. (Providence)."},{"key":"10.1016\/j.ejps.2016.09.028_bb0010","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000321044","article-title":"Nasal drug delivery in humans","volume":"40","author":"Bitter","year":"2011","journal-title":"Curr. Probl. Dermatol."},{"key":"10.1016\/j.ejps.2016.09.028_bb0015","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/humrep\/13.4.811","article-title":"Induction of the endogenous gonadotrophin surge for oocyte maturation with intra-nasal gonadotrophin-releasing hormone analogue (buserelin): effective minimal dose","volume":"13","author":"Buckett","year":"1998","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.ejps.2016.09.028_bb0020","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1056\/NEJM198502213120802","article-title":"Acquired ciliary defects in nasal epithelium of children with acute viral upper respiratory infections","volume":"312","author":"Carson","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejps.2016.09.028_bb0025","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jconrel.2014.05.003","article-title":"Chitosan in nasal delivery systems for therapeutic drugs","volume":"190","author":"Casettari","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2016.09.028_bb0030","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ijpharm.2010.08.030","article-title":"Characterization and in vitro evaluation of freeze-dried microparticles composed of granisetron-cyclodextrin complex and carboxymethylcellulose for intranasal delivery","volume":"400","author":"Cho","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2016.09.028_bb0035","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1208\/s12248-009-9144-x","article-title":"Prediction of solubility and permeability class membership: provisional BCS classification of the world's top oral drugs","volume":"11","author":"Dahan","year":"2009","journal-title":"AAPS J."},{"key":"10.1016\/j.ejps.2016.09.028_bb0040","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.jsps.2014.09.001","article-title":"Influence of different types of low substituted hydroxypropyl cellulose on tableting, disintegration, and floating behaviour of floating drug delivery systems","volume":"23","author":"Di\u00f3s","year":"2015","journal-title":"Saudi Pharm J."},{"key":"10.1016\/j.ejps.2016.09.028_bb0045","first-page":"189","article-title":"Aerodiol: the efficacy and tolerability of intranasal estrogen administration","volume":"55","author":"Genazzani","year":"2003","journal-title":"An overview. Minerva Ginecol."},{"key":"10.1016\/j.ejps.2016.09.028_bb0050","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/10611869308996066","article-title":"Review: clinical opportunities provided by the nasal administration of peptides","volume":"1","author":"Harris","year":"1993","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ejps.2016.09.028_bb0055","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0378-5173(81)90058-2","article-title":"Absorption of drugs from the nasal mucosa of rat","volume":"7","author":"Hirai","year":"1981","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2016.09.028_bb0065","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0385-8146(98)00062-5","article-title":"Topical treatment of nasal polyps with a beclomethasone dipropionate powder preparation","volume":"26","author":"Irifune","year":"1999","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.ejps.2016.09.028_bb0070","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0378-5173(01)00736-0","article-title":"Improved nasal bioavailability of elcatonin by insoluble powder formulation","volume":"224","author":"Ishikawa","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2016.09.028_bb0075","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1023\/A:1019881706159","article-title":"Insoluble powder formulation as an effective nasal drug delivery system","volume":"19","author":"Ishikawa","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2016.09.028_bb0080","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00228-003-0682-3","article-title":"A replicate study design for testing bioequivalence: a case study on two desmopressin nasal spray preparations","volume":"59","author":"Joukhadar","year":"2003","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2016.09.028_bb0085","first-page":"255","article-title":"Analgesic efficacy of Famalgin and Imigran in patients with acute migraine attacks","volume":"56","author":"Jovici\u0107","year":"1999","journal-title":"Vojnosanit. Pregl."},{"key":"10.1016\/j.ejps.2016.09.028_bb0090","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0169-409X(97)00059-8","article-title":"Nasal mucociliary clearance as a factor in nasal drug delivery","volume":"29","author":"Merkus","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2016.09.028_bb0095","first-page":"113","article-title":"Clinical study on beclomethasone dipropionate powder preparation (TL-102) in perennial nasal allergy","volume":"24","author":"Okuda","year":"1986","journal-title":"Rhinology"},{"key":"10.1016\/j.ejps.2016.09.028_bb0100","first-page":"1","article-title":"Dry powder nasal drug delivery: challenges, opportunities and a study of the commercial Teijin Puvlizer Rhinocort device and formulation","volume":"22","author":"Pozzoli","year":"2016","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejps.2016.09.028_bb0105","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/andr.12137","article-title":"Natesto\u2122, a novel testosterone nasal gel, normalizes androgen levels in hypogonadal men","volume":"4","author":"Rogol","year":"2016","journal-title":"Andrology."},{"key":"10.1016\/j.ejps.2016.09.028_bb0110","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1023\/A:1015830907632","article-title":"The nasal mucociliary clearance: relevance to nasal drug delivery","volume":"8","author":"Schipper","year":"1991","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2016.09.028_bb0115","first-page":"1","article-title":"Poloxamer 407-based intranasal thermoreversible gel of zolmitriptan-loaded nanoethosomes: formulation, optimization, evaluation and permeation studies","volume":"12","author":"Shelke","year":"2016","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejps.2016.09.028_bb0120","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1248\/bpb.b110731","article-title":"Bovine serum albumin as a lyoprotectant for preparation of DNA dry powder formulations using the spray-freeze drying method","volume":"35","author":"Tsukamoto","year":"2012","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejps.2016.09.028_bb0125","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/j.addr.2005.07.009","article-title":"Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives","volume":"57","author":"Ugwoke","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2016.09.028_bb0130","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1159\/000080471","article-title":"Hemostatic and fibrinolytic response to nasal desmopressin in hemodialysis patients","volume":"13","author":"Ulusoy","year":"2004","journal-title":"Med. Princ. Pract."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098716303931?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098716303931?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T03:34:41Z","timestamp":1536377681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098716303931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":25,"alternative-id":["S0928098716303931"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2016.09.028","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nasal drug absorption from powder formulations: The effect of three types of hydroxypropyl cellulose (HPC)","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2016.09.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}